Skip to menu Skip to content Skip to footer

2006

Conference Publication

Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients

Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients. The 6th Annual Health and Medical Research Conference of Queensland, Brisbane, Australia, 23-24 November 2006. Brisbane, Australia: Queensland Health.

Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients

2006

Conference Publication

A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis

Hennig, S., Wainwright, C. E., Bell, S., Miller, H., Charles, B. G. and Duffull, S. B. (2006). A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis. 15th Annual Meeting of the Population Approach Group in Europe, Bruges, Belgium, 14-16 June 2006. PAGE.

A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis

2006

Journal Article

Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients

Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients. Clinical Pharmacokinetics, 45 (11), 1099-1114. doi: 10.2165/00003088-200645110-00004

Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients

2006

Conference Publication

Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT)

Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT). PAGANZ 06 9th Annual Scientific Meeting, Auckland New Zealand / School of Medicine, 7-9 February 2006. Brisbane, Australia: Poppulation Approach Group in Australia and New Zealand.

Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT)

2006

Book Chapter

Cystic Fibrosis Infection with Clonal Strains of Pseudomonas Aeruginosa: Current Knowledge and Future Management

Jones, A. M. and Bell, S. C. (2006). Cystic Fibrosis Infection with Clonal Strains of Pseudomonas Aeruginosa: Current Knowledge and Future Management. Cystic Fibrosis. (pp. 105-126) edited by K. Webb and F. Ratjen. London: Maney Publishing.

Cystic Fibrosis Infection with Clonal Strains of Pseudomonas Aeruginosa: Current Knowledge and Future Management

2006

Conference Publication

Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients

Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients. Population Approach Group Europe: 15th Meeting, Bruges, Belgium, 14-16 June 2006. PAGE.

Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients

2005

Journal Article

Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions

Hill, Dominic, Rose, Barbara, Pajkos, Aniko, Robinson, Michael, Bye, Peter, Bell, Scott C., Elkins, Mark, Thompson, Barbara, MacLeod, Colin, Aaron, Shawn D. and Harbour, Colin (2005). Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Journal of Clinical Microbiology, 43 (10), 5085-5090. doi: 10.1128/JCM.43.10.5085-5090.2005

Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions

2005

Journal Article

MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?

Downey, D. G., Kidd, T. J., Coulter, C. and Bell, S. C. (2005). MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?. Journal of Cystic Fibrosis, 4 (3), 205-207. doi: 10.1016/j.jcf.2005.05.014

MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?

2005

Journal Article

Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis

Buntain, Helen M., Greer, Ristan M., Wong, Joseph C.H., Schluter, Philip J., Batch, Jennifer, Lewindon, Peter, Bell, Scott C. and Wainwright, Claire E. (2005). Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis. Journal of Paediatrics And Child Health, 41 (7), 317-322. doi: 10.1111/j.1440-1754.2005.00635.x

Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis

2005

Journal Article

Has the time come to prescribe azithromycin in cystic fibrosis patients?

McCormack, J. G. and Bell, S. C. (2005). Has the time come to prescribe azithromycin in cystic fibrosis patients?. Internal Medicine Journal, 35 (2), 73-74. doi: 10.1111/j.1445-5994.2004.00762.x

Has the time come to prescribe azithromycin in cystic fibrosis patients?

2005

Conference Publication

Antibiotics for acute exacerbations of COPD: A systematic review

Yang, I. A., Kim, S. T. and Bell, S. C. (2005). Antibiotics for acute exacerbations of COPD: A systematic review. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Antibiotics for acute exacerbations of COPD: A systematic review

2005

Conference Publication

The effect of mucoidy on biofilm formation in cystic fibrosis clinical isolates

Semple, K., Senini, S., Serisier, D., Bowler, S., Bell, S. and McCormack, J. (2005). The effect of mucoidy on biofilm formation in cystic fibrosis clinical isolates. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

The effect of mucoidy on biofilm formation in cystic fibrosis clinical isolates

2005

Conference Publication

A study of desensitisation procedures to beta-lactam antibiotics in adult patients with cystic fibrosis: An update

Burrows, J., Nissen, L. M., Kirkpatrick, C. M. J. and Bell, S. C. (2005). A study of desensitisation procedures to beta-lactam antibiotics in adult patients with cystic fibrosis: An update. Sixth Australian & New Zealand Cystic Fibrosis Conference, Adelaide, 20-23 Aug. 2005. Australia:

A study of desensitisation procedures to beta-lactam antibiotics in adult patients with cystic fibrosis: An update

2005

Conference Publication

Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype

Kim, S. T., Passmore, L., Dent, A. G., Slaughter, R., Yang, I. A., Fong, K. M., Zimmerman, P. V. and Bell, S. C. (2005). Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype

2005

Conference Publication

Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis

Kermeen, F. D., Kim, S. T., Kidd, T. J., Coulter, C., Greer, R. M. and Bell, S. C. (2005). Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis. 28th European Cystic Fibrosis Conference, Crete, Greece, 22-25 June 2005. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/S1569-1993(05)80113-4

Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis

2005

Journal Article

Macrolides in cystic fibrosis

Bell, S. C., Senini, S. L. and McCormack, J. G. (2005). Macrolides in cystic fibrosis. Chronic Respiratory Disease, 2 (2), 85-98. doi: 10.1191/1479972305cd066rs

Macrolides in cystic fibrosis

2005

Conference Publication

Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis

Kermeen, F. D., Kim, S. T., Kidd, T. J., Coulter, C., Greer, R. M. and Bell, S. C. (2005). Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, WA, Australia, 18-23 March 2005. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis

2005

Conference Publication

Antibiotics in cystic fibrosis (CF): A systematic review

Kim, S. T., Yang, I. A. and Bell, S. C. (2005). Antibiotics in cystic fibrosis (CF): A systematic review. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Antibiotics in cystic fibrosis (CF): A systematic review

2005

Conference Publication

Antibiotics in cystic fibrosis (CF): A systematic review

Kim, S. T., Yang, I. A. and Bell, S. C. (2005). Antibiotics in cystic fibrosis (CF): A systematic review. Array, Crete, Greece, 22-25 Jun, 2005. Amsterdam, Netherlands: Elsevier BV.

Antibiotics in cystic fibrosis (CF): A systematic review

2005

Journal Article

Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multi-resistant bacteria: A randomised, double-blind, controlled clinical trial

Aaron, Shawn D., Vandemheen, Katherine L., Ferris, Wendy, Fergusson, Dean, Tullis, Elizabeth, Haase, David, Berthiaume, Yves, Brown, Neil, Wilcox, Pearce, Yozghatlian, Veronica, Bye, Peter, Bell, Scott, Chan, Francis, Rose, Barbara, Jeanneret, Alphonse, Stephenson, Anne, Noseworthy, Mary, Freitag, Andreas, Paterson, Nigel, Doucette, Steve, Harbour, Colin, Ruel, Michel and MacDonald, Noni (2005). Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multi-resistant bacteria: A randomised, double-blind, controlled clinical trial. The Lancet, 366 (9484), 463-471. doi: 10.1016/S0140-6736(05)67060-2

Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multi-resistant bacteria: A randomised, double-blind, controlled clinical trial